AzTrials
AzTrials

MeshLLLT vs HANCT07205640

Improving Healing in Children After Tooth Extraction Using Laser Therapy or Hyaluronic Acid

A study testing Low-Level Laser Therapy and Hyaluronic Acid (HA) in people with Mesh and Healthy Volunteer, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Tooth extraction may be an unpleasant and painful experience for children, Post-extraction wound healing. Low-level laser therapy (LLLT) is a widely used adjuvant treatment for wound healing, resulting in both an increase in cell number and an increase in cell metabolism. Read more about this study

Who is it for?
Ages 6 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Mesh, Healthy Volunteer, Low Level Laser Therapy
What is being tested?
Low-Level Laser Therapy and Hyaluronic Acid (HA)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteEgypt
Study dates
1 Dec 2025to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children aged from six to ten years.
  • Children of both genders.
  • Children with badly decayed first permanent molar beyond repair and indicated for extraction.
  • Parents acceptance to participate in the study.

Who cannot join

  • Medically compromised children.
  • Uncooperative children.
  • Children who will not attend the follow up visits

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mona Ali Abd Elhafiz, BDS contact

+201000323801

info@cu.edu.eg

Mona Ali AbdelHafiz, BDS contact

+201000323801

mona.ali@dentistry.cu.edu.eg

Egypt1 site
  • Faculty Of Oral & Dental Medicine - Cairo University

    Giza, EL Menial, 12613

Other trials in Egypt

About this study

Official title: Effect of Low-Level Laser Therapy Versus Hyaluronic Acid on Wound Healing After First Permanent Molar Extraction in Children.

Tooth extraction may be an unpleasant and painful experience for children, Post-extraction wound healing. Low-level laser therapy (LLLT) is a widely used adjuvant treatment for wound healing, resulting in both an increase in cell number and an increase in cell metabolism. HA it is an important component of the extracellular matrix and a constituent of the neural, connective, and epithelial tissues.

Read the detailed description

Tooth extraction may be an unpleasant and painful experience for children. Pain felt during dental treatment, especially tooth extraction, is the most common complication. Pain management during and after tooth extraction is part of behavioral guidance, especially in pediatric patients.

Post-extraction wound healing and pain perception are related to hostrelated factors such as the patient's immune system, the use of painkillers and antibiotics, the presence of infection in the region, and the atraumatic nature of the procedure. Low-level laser therapy (LLLT) is a widely used adjuvant treatment for wound healing. It is based on the idea that exposure to a specific wavelength can alter cellular behavior, resulting in both an increase in cell number and an increase in cell metabolism. Aside from not having any negative effects, LLLT is an a thermic, photobiological, and nondestructive therapy approach.

HA it is an important component of the extracellular matrix and a constituent of the neural, connective, and epithelial tissues. Among the many biological effects of HA are its functions in cell differentiation, wound healing, inflammation, embryological development, and viscoelasticity.

Being tested
Low-Level Laser Therapy, Hyaluronic Acid (HA)
Keywords
hyaluronic acid, low level laser therapy, tooth extraction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-Level Laser TherapyDevice

    A 980 nm diode laser will be applied immediately after extraction of the first permanent molar. The laser will be used in continuous mode at 0.5 W, with a total energy of 300 J, applied for 60 seconds at three points around the extraction socket.

  • Hyaluronic Acid (HA)Drug

    Hyaluronic acid gel will be applied directly into the extraction socket immediately after tooth removal.

Study groups in NCT07205640
Study groupRoleWhat they receive
Low-Level Laser Therapy (LLLT)ExperimentalParticipants in this arm will receive low-level laser therapy (LLLT) immediately after extraction of the first permanent molar.
Receives: Device: Low-Level Laser Therapy
Hyaluronic Acid (HA)ExperimentalParticipants in this arm will receive hyaluronic acid (HA) immediately after extraction of the first permanent molar.
Receives: Drug: Hyaluronic Acid (HA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. wound size

    Wound size unit of measure : mm (millimeters) (mesiodistal and buccolingual dimension of each socket).

    Measured: 7 days

Secondary outcomes (4)
  1. Tissue Color Changes

    Gingival color assessed using the Landry, Turnbull, and Howley Index (normal vs inflamed).

    Unit of Measure: Binary (normal / inflamed)

    Measured: Day 0, Day 3, and Day 7 post-extraction.

  2. Bleeding Upon Palpation

    Presence or absence of bleeding when palpating the extraction site.

    Unit of Measure: Binary (yes / no)

    Measured: Day 0, Day 3, and Day 7 post-extraction.

  3. Pus Presence

    Presence or absence of pus at the extraction site.

    Unit of Measure: Binary (yes / no)

    Measured: Day 0, Day 3, and Day 7 post-extraction.

  4. Pain Level During Application

    Pain assessed using Wong-Baker Faces Pain Rating Scale (0 = no pain, 10 = worst pain).

    (0 = no pain, 10 = worst pain). Higher scores indicate worse outcomes.

    Measured: Immediately after intervention (Day 0).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start1 Dec 2025 (estimated)
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07205640
Sponsor's protocol ID
LLLTvsHA-2025
Acronym
LLLT vs HA
Status last verified
Sep 2025
First submitted
8 Aug 2025
Last updated
3 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This is an academic master's degree study. The individual participant data (IPD) will not be shared outside the study team to ensure patient confidentiality. Only aggregate results will be published.

Questions about this trial

What is this clinical trial studying?

A study testing Low-Level Laser Therapy and Hyaluronic Acid (HA) in people with Mesh and Healthy Volunteer, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mona Ali Abd Elhafiz, BDS (+201000323801, info@cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

wound size (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in